129 results for «100»
129 results
Recruitment complete in FEVAR study for on-label use with Bentley BeGraft as bridging stent
21 Jul 2022
Hypertension management in 2022: Latest data on renal denervation - EuroPCR 2022
17 May 2022
On the occasion of World Hypertension Day, Felix Mahfoud speaks about the value of renal denervation, including the latest data and what we can learn about renal denervation at EuroPCR 2022.
Author
Four-Year Outcomes from the EVOLUT Low Risk Trial
26 Oct 2023
Dejan Milasinovic provides his take on the EVOLUT Low Risk trial, presented by Michael I. Reardon at TCT Congress 2023. 4-year results reveal a continuing trend towards lower combined rates of all-cause mortality and disabling stroke with TAVI compared with surgical aortic valve replacement (SAVR)
Author
COVID-19: safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine (Sputnik V)
18 Feb 2021
Examination of the study methodology and results according to the PICOT principle, SWOT analysis and real-world applicability
STOPDAPT-2 ACS: exploring the limits of short DAPT
31 Aug 2021
Hirotoshi Watanabe (Kyoto, Japan) presented the results of the STOPDAPT-2 ACS trial in a Hot Line session of the ESC Congress 2021. Dejan Milasinovic provides his analysis of this study.
Author
Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease.
25 Apr 2023
Case report: Renal denervation using ultrasound energy (uRDN)
23 Oct 2024
In this case report, we examine an advanced technique for renal denervation (RDN)—ultrasound energy—employed to manage severe hypertension in patients with complex medical histories.
Author
Pivotal study on the ShortCut transcatheter aortic valve leaflet splitting device
16 May 2024
Coronary obstruction is a major concern in patients undergoing TAVI for degenerated bioprostheses (valve-in-valve [ViV]) and is associated with a 30-day mortality rate of around 50%.1 While several transcatheter techniques to lacerate bioprosthetic valve leaflets prior to TAVI placement (such as BASILICA) have been described, they are...
2026 Andreas Grüntzig Ethica Awardee: Roxana Mehran
20 May 2026
The Andreas Grüntzig Ethica Award – the highest honour in the interventional cardiology community – is presented to individuals who have contributed in an extraordinary way to the PCR mission.
Self-made steerable catheter to cross the aortic valve in severe aortic stenosis
15 Apr 2026
When standard catheters and wires repeatedly fail to cross a severely stenotic aortic valve, a simple modification of readily available equipment may provide a solution.
This step-by-step tutorial explains how to create and use a self-made steerable catheter system to facilitate valve crossing in complex TAVI anatomies.
Author
Author
Author
Robocath demonstrates feasibility of robotic carotid stenting in ‘CARE’ clinical trial conducted at Rennes University Hospital
19 Oct 2023
2024 ESC Guidelines: Peripheral arterial and aortic diseases - Focus on Peripheral Arterial Diseases
09 Sep 2024
The 2024 ESC Guidelines for aortic diseases, merged with peripheral arterial disease guidelines, update prior guidance and emphasize atherosclerotic conditions. In this article, Antoine Sauguet summarizes the content related to peripheral arterial diseases.
Author
EuroPCR 2024: Primary outcomes from PINNACLE I clinical trial establish safety and effectiveness of Elixir Medical’s Hertz Contact Intravascular Lithotripsy System for calcium fragmentation in moderate to severe calcified coronary artery lesions
16 May 2024
Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial
31 Mar 2025
Mirvat Alasnag provides her take on the Altshock-2 randomized clinical trial which was presented by Alice Sacco at ACC.25 in Chicago.
Author
EuroPCR 2021 - Unprecedented global outreach and online interactivity during an innovative livestreamed edition
25 May 2021
Paris, France. 21 May 2021. Since 1989, EuroPCR has constantly pioneered innovative educational tools and formats to help the interventional cardiovascular community effectively share their knowledge, skills and practice. Rising up to the challenge of the pandemic, the 31st annual edition was fundamentally rethought, reshaped and...
Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
01 Sep 2022
Daniele Giacoppo analyses the results of the SCAAR registry which compared patients with STEMI treated by primary PCI in Sweden from January 2008 to December 2016 according to the UFH pretreatment status...
Author
EuroPCR 2023: Late-Breaking Clinical Data Demonstrate Elixir Medical’s DynamX Bioadaptor Restores Vessel Motion and Function with Better Effectiveness at 12 Months Compared to a Leading Drug-Eluting Stent (DES)
17 May 2023
One-year results from the FUTURE-II trial
18 May 2021
A decade already passed from the first use of bioresorbable vascular scaffold in percutaneous coronary interventions. The first studies - by using surrogate endpoints - showed some superiority of BRS vs. metallic drug-eluting stent in terms of the so-called vascular restoration therapy with recovery of vasomotion...
FIRE1 raises $25M to revolutionize heart failure home monitoring
15 Mar 2023
New data highlight promising angiographic and safety profile of BIOTRONIK’s third generation resorbable magnesium scaffold
16 Mar 2023